We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.0025 | -0.42% | 0.5975 | 0.00 | 16:35:24 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.55 | 0.645 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Food Preparations, Nec | 390k | -385k | -0.0002 | -30.00 | 13.31M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.5975 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/9/2024 | 13:43 | ALNC |  EARNINGS: Katoro Gold pretax loss narrows; Ondine Biomedical sales up |
| 30/9/2024 | 07:00 | UK RNS | Provexis PLC Final Results |
| 30/4/2024 | 17:00 | UK RNS | Provexis PLC Total Voting Rights |
| 03/4/2024 | 10:59 | ALNC | TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit |
| 28/3/2024 | 07:00 | UK RNS | Provexis PLC Issue of Equity - purchase of Fruitflow® II SD |
| 29/12/2023 | 13:57 | ALNC | IN BRIEF: Provexis first-half loss widens but positive for Fruitflow |
| 29/12/2023 | 12:48 | UKREG | Provexis PLC Half-year Report |
| 26/10/2023 | 13:51 | UKREG | Provexis PLC Result of AGM |
Provexis (PXS) Share Charts1 Year Provexis Chart |
|
1 Month Provexis Chart |
Intraday Provexis Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 04/10/2024 | 09:32 | Provexis: a new beginning | 2,752 |
| 30/9/2020 | 20:59 | PROVEXIS PLC (Sirco) | 40,155 |
| 27/4/2013 | 12:43 | Blatherskites, trolls, bashers & duplicitous 'investors' | 631 |
| 04/9/2012 | 17:24 | PXS herd mentality, medicine, moneymen and manipulation | 3,710 |
| 20/6/2012 | 01:07 | The Pixies 'Time To Grow Your Tomatoes' Thread | 54 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 06/10/2024 09:20 by Provexis Daily Update Provexis Plc is listed in the Food Preparations, Nec sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.60p.Provexis currently has 2,217,821,523 shares in issue. The market capitalisation of Provexis is £13,306,929. Provexis has a price to earnings ratio (PE ratio) of -30.00. This morning PXS shares opened at - |
Posted at 03/10/2024 12:14 by bareknee RPGross Margin was always going to fall off a cliff once the AA fell out of the equation. Pre us being responsible for sales we had FF+ contributing at ~65% GM and the AA income had no ( gross ) costs associated with it so effectively had an infinite GM. Once we're responsible for sales the whole situation changes so we get more revenue, but at a much reduced margin. In an ideal world Ford should have fleshed out his previous statements on "like for like" and pointed out that the royalties would mean our margins could well be worse. On the face of it, if revenues from FF are broadly the same now as they were under DSM then the profit share we used to take isn't currently massively different to the royalty DSM are now taking. Ford, probably via his advisors, tends to sail a bit close to the wind in making the Annual and Interims clear and unambiguous. In some ways you can see his background is numbers and not words, because the words frequently aren't helpful. On Cost Of Goods, you know better than me that it's not just the cost you bought the goods at ( or the replacement cost ) but can include storage costs and the like. It seems unusual to me to include royalties there, but it's not unheard of to do so. At least he's clarified that this time round, though it should have been made clear from the start. |
Posted at 15/8/2024 17:16 by bareknee SmithiePart of what you say is true, but to get there your workings out are a bit ropey. The bit that I'd say you're right about relates to cashflow and PXS having to, or choosing to, issue shares to DSM Firmenich as part payment for a batch of FF. When the results come out in September we'll know, or have a very good idea, as to whether or not we had the cash to pay for that FF and continue operating or not. I suspect we didn't, so it was a way of keeping the wheels turning until we're either cashflow positive, can borrow against future sales or issue more shares in a placing. So there's a big risk there. Where your working out is dodgy relates to the B2B relationship between PXS and DSM. They don't make Fruitflow, they just have some in store which they pretty much can't sell to anyone except PXS, so it's an unusual situation and will likely unravel quite soon ( if it hasn't already ). At that point PXS will have to go to the manufacturer which supplied FF to DSM and negotiate a contract. The issues on cashflow will almost certainly be the same as they are between us and DSM now and, if they can't be resolved, then it's Goodnight Vienna time. Previously our Chief Exec has been able to keep things going via placings,so that's the obvious route to go. What we don't know is if, or more likely when the Chinese company ByHealth, who want to launch over there, will get permission from their regulator. If they get that permission in a timely manner and put decent sized orders in, then borrowing against that gets much easier, as does convincing people to take part in a placing. At that point the hope is that PXS is then profitable, has manageable cashflow and becomes a proper business. What the share price was years ago is immaterial. It was plainly massively overvalued, but that's in the past. |
Posted at 15/8/2024 15:48 by smithie6 was this doing Fruitflow etc in 2009 ?The share price was 15p. It is now 2024, 15 years later. let us say that with inflation that 15p then is worth +50% now, in the money of 2024 = 22p. So, 22p in 2009, & now 0.6p. At first glance that looks a complete disaster. And the company does not have the cash to buy in some product from a distributor. Behind the smoke & mirrors perhaps there is good news, but imo it does not look pretty. |
Posted at 15/8/2024 15:43 by smithie6 ...one can look at it from different viewpointsone viewpoint is that the co. does not have enough cash to buy product from a stockist imo that is bad & it probably continues a never ending sequence of dilution & more dilution ... imo that is also bad. ---- & from my viewpoint the owner of the IP, PXS, should be receiving cash generated from sales which for PXS should imo be globally located re-sellers/agents so, imo, PXS should not be buying stock from a seller, the seller should be selling it shops & Joe Public....it infers that the agent was not able to sell it, imo. stock coming back to PXS is not a +ve sign imo |
Posted at 14/8/2024 06:29 by gix er You assume wrong.PXS has never issued shares to the manufacturer of the product (Fruitflow). However, what PXS did do was buy some of the remaining stock of Fruitflow from their second largest shareholder and former sole distributor of Fruitflow (DSM) and issued shares to the company for this buy back. DSM can still sell Fruitflow but now not as a raw material. Good move for both parties I would say. As for the cash position, the results will be released soon so that will be clear to everyone. Its all on the company website under "Regulatory news" if you care to get the correct information. |
Posted at 13/8/2024 20:23 by smithie6 ..what's the story here nowadays ?...the owns intel. prop. in some food product which apparently has some health benefits, yes ? but to obtain the product to then supply it to others the co. has to issue a lot of shares to some overseas third party, who apparently make the product, yes ? so, one assumes that PXS itself is virtually bankrupt since it can not pay cash to obtain its own product, to then sell it (at a higher price) All seems "very strange" to me. Surely, normal business practice would be that the mfr makes the stuff, supplies it to PXS (with an invoice asking to be paid) & PXS ships the stuff to clients for cash on delivery or cash in say 10 days. And then PXS pays the product mfr, within 60-90 days. And everyone is happy. And PXS keeps the nett gross profit on its sales. Step & repeat. but no, PXS issues 2% of the shares of PXS to the product mfr. !! seems insane to me. The only logical justification I can see is that PXS is verging on bankruptcy & no one is willing to supply the product without getting paid at delivery, & PXS can not pay, since it pays using shares. It all seems a bit strange imo. ====== Other companies that have relentlessly issued new shares include Craven House. Another disaster. ---- looking at the "all time" chart for PXS, it looks similar perhaps to a hospital monitor display for someone and the last activity on the monitor was in 2010 ! ...& that since then it has just flat lined ! While on the 2 year chart it looks like the sick patient briefly wakes up once per year...only to then slide further downhill ! |
Posted at 28/6/2024 19:17 by sigma3333 IF has boxed pxs into a corner controlled by the Chinese government. If blue cap isn’t granted what happens after the share price collapse ?ciggy |
Posted at 27/6/2024 11:15 by redprince From poorly updated website and last minute notice of agm's and 11th hour accounts it all smacks of a total lack of respect to pi's.The shareholders have not in any way held the bod to account. Neither have DSM been held to account. The last agm i attended (years ago) had half the attendees made up of paid for flunkeys who were contracted in for various things.I remember Buck saying how wonderful it was to have had a get together with them all ... The share price and lack of revenue say it all and are totally out of kilter with IF's remuneration and undemanding share options. This company is the perfect example of the worst of AIM. In what other world could the FD literally relocate himself to the other side of the world for years and noone actually know about it. |
Posted at 17/6/2024 07:50 by huntergls Hopefully all the users will come direct to PXS for there Ff+. More money for us. H&B were supposed to promote this really well and even have staff training on the benefits of the product. Did not really happen as far as I know. Only really stocked in bigger stores then it reduced to outlets. I think we are now getting to the position where PXS are selling fruitflow to bigger fish. It's a nice little earner for us with also some small advertising effect. Hopefully we will have some news before the AGM which is not far away. A great time to buy still while the shares are under a penny. I for one will be buying. Seems SL is happy to hold what he has for now. I for one will not be voting for any TO with my 22 million shares. Aim is a a gamble with IMO some dodgy CEO but IF is certainly not one of them. Maybe nieve at times but very approachable. GLA |
Posted at 07/6/2024 11:51 by redprince I do not believe there will be a sustained rerating of our share price following a planned launch by B-H.Why?Well when you consider we were told they would launch before end of 2017 it says a lot.Also this co is much more a lifestyle co for IF than it is about rewarding shareholders - who have seen zero reward in nearly 15 years. Also consider the reality of further fund raising and look at the co's history of being a serial disappointer/non achiever. DSM could noot even get behind MM and drop their non exclusivity clause for the UK market despite their being zero interest from elsewhere and a co in MM who were ready to fully promote a shot format product. Simply put we have allowed successive years of serial abysmal performance to be rewarded with non deserving pay and thoroughly undemanding share options. There are a few day dreamers on the red channel but they have only shown themselves to be naiveley foolish and in one case it is more a case of an ego that refuses to admit they have been wrong for years. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
